Cite
MLA Citation
Cornelis van Tilburg et al.. “CTNI-30. LOGGIC/FIREFLY-2: A PHASE 3, RANDOMIZED TRIAL OF TOVORAFENIB VS. CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED LOW-GRADE GLIOMA HARBORING AN ACTIVATING RAF ALTERATION.” Neuro-oncology, vol. 24, n.d., pp. vii77–vii78. http://access.bl.uk/ark:/81055/vdc_100169741944.0x000033